An update from AngioDynamics ( (ANGO) ) is now available.
On April 2, 2025, AngioDynamics will host a virtual Cardiovascular Investor Event, highlighting its innovative technologies and improved patient outcomes in cardiovascular care. The event underscores AngioDynamics’ strategic focus on growth within the high-growth cardiovascular disease market, leveraging its comprehensive portfolio and differentiated technologies to strengthen its competitive position.
More about AngioDynamics
AngioDynamics is a diversified medical technology company focused on expanding treatment options and improving patient outcomes in the fields of cardiovascular disease and cancer. The company emphasizes innovative research and development, clinical and regulatory expansion, and customer-centric sales performance.
YTD Price Performance: 7.57%
Average Trading Volume: 695,931
Technical Sentiment Signal: Sell
Current Market Cap: $380M
See more insights into ANGO stock on TipRanks’ Stock Analysis page.